
USA - New York Stock Exchange - NYSE:HNGR - US41043F2083 - Common Stock
The current stock price of HNGR is 18.72 USD. In the past month the price increased by 0.11%. In the past year, price decreased by -16.2%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 18.24 | 107.67B | ||
| THC | TENET HEALTHCARE CORP | 12.57 | 17.14B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 10.81 | 14.05B | ||
| EHC | ENCOMPASS HEALTH CORP | 21.04 | 10.95B | ||
| ENSG | ENSIGN GROUP INC/THE | 28.3 | 10.23B | ||
| PACS | PACS GROUP INC | 91.26 | 5.43B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 15.62 | 2.50B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 2.51B | ||
| NHC | NATIONAL HEALTHCARE CORP | 20.93 | 2.18B | ||
| SGRY | SURGERY PARTNERS INC | 20.26 | 2.04B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 17.45 | 1.86B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 5.61 | 1.34B |
Hanger, Inc. provides orthotic and prosthetic patient care products and services. The company is headquartered in Austin, Texas and currently employs 5,200 full-time employees. The firm provides orthotic and prosthetic (O&P) services, distribute O&P devices and components, manage O&P networks, and provide therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings. The company operates through two segments: Patient Care, and Products & Services. Its Patient Care segment is primarily comprised of Hanger Clinic, which specializes in comprehensive, outcomes-based design, fabrication, and delivery of custom O&P devices through approximately 760 patient care clinics and 115 satellite locations in 47 states and the District of Columbia. The company also provides payor network contracting services to other O&P providers through this segment. Its Products & Services segment is comprised of its distribution services and therapeutic solutions businesses.
HANGER INC
Suite 300, 10910 Domain Drive
Austin TEXAS 78758 US
CEO: Vinit K. Asar
Employees: 5200
Phone: 15127773800.0
Hanger, Inc. provides orthotic and prosthetic patient care products and services. The company is headquartered in Austin, Texas and currently employs 5,200 full-time employees. The firm provides orthotic and prosthetic (O&P) services, distribute O&P devices and components, manage O&P networks, and provide therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings. The company operates through two segments: Patient Care, and Products & Services. Its Patient Care segment is primarily comprised of Hanger Clinic, which specializes in comprehensive, outcomes-based design, fabrication, and delivery of custom O&P devices through approximately 760 patient care clinics and 115 satellite locations in 47 states and the District of Columbia. The company also provides payor network contracting services to other O&P providers through this segment. Its Products & Services segment is comprised of its distribution services and therapeutic solutions businesses.
The current stock price of HNGR is 18.72 USD.
HNGR does not pay a dividend.
HNGR has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
8 analysts have analysed HNGR and the average price target is 23.84 USD. This implies a price increase of 27.36% is expected in the next year compared to the current price of 18.72.
The Revenue of HANGER INC (HNGR) is expected to grow by 7.98% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ChartMill assigns a technical rating of 8 / 10 to HNGR. When comparing the yearly performance of all stocks, HNGR is one of the better performing stocks in the market, outperforming 89.74% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to HNGR. HNGR has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months HNGR reported a non-GAAP Earnings per Share(EPS) of 0.99. The EPS increased by 32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.17% | ||
| ROA | 3.86% | ||
| ROE | 29.78% | ||
| Debt/Equity | 3.71 |
8 analysts have analysed HNGR and the average price target is 23.84 USD. This implies a price increase of 27.36% is expected in the next year compared to the current price of 18.72.
For the next year, analysts expect an EPS growth of 18.65% and a revenue growth 7.98% for HNGR